Transcription factor LSF (TFCP2) inhibits melanoma growth

Oncotarget. 2016 Jan 19;7(3):2379-90. doi: 10.18632/oncotarget.6230.

Abstract

Late SV40 factor 3 (LSF), a transcription factor, contributes to human hepatocellular carcinoma (HCC). However, decreased expression level of LSF in skin melanoma compared to that in benign melanocytic tumors and nevi in mice and humans was found in this study. Anchorage-dependent and -independent growth of melanoma cells was suppressed by LSF overexpression through an increased percentage of G1 phase cells and an increased p21CIP1 expression level in vitro and in vivo. Anchorage-dependent growth in LSF-overexpressed melanoma cells was promoted by depletion of LSF in the LSF-overexpressed cells. Integrated results of our EMSA and chromatin immunoprecipitation assays showed binding of LSF within a 150-bp upstream region of the transcription start site of p21CIP1 in melanoma cells. Taken together, our results suggest potential roles of LSF as a growth regulator through control of the transcription of p21CIP1 in melanocytes and melanoma cells as well as a biomarker for nevus.

Keywords: CDKN1A; TFCP2; cell cycle; melanoma; transcription factor LSF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Chromatin Immunoprecipitation
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics*
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics*
  • Electrophoretic Mobility Shift Assay
  • G1 Phase Cell Cycle Checkpoints / genetics
  • Humans
  • Melanocytes / metabolism
  • Melanoma, Experimental / pathology*
  • Mice
  • Skin Neoplasms / pathology*
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics*

Substances

  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • DNA-Binding Proteins
  • TFCP2 protein, human
  • Transcription Factors